Medpark-Backed Yetsea Medical Showcases Premium Ophthalmic Devices at Major Industry Conference
Yesight
Ophthalmic Medical Device R&D and Manufacturer
Recently, the 29th Ophthalmology Academic Conference of the Chinese Medical Association was successfully held in Hangzhou. Ophthalmology experts from across China and around the world gathered to focus on the cutting-edge developments in ophthalmology and discuss academic innovation and clinical practice. During the conference, Medpark’s invested and incubated company Yesight showcased several star products with great success.
At the同期举办的超广角多模态眼底影像新技术研讨会 held concurrently, Yesight's "耀·星海" series flagship ultra-widefield laser scanning ophthalmoscope (SLO) Yetsea 300 garnered significant attention from attending experts due to its exceptional technical capabilities and outstanding clinical performance.
Yetsea 300With 168° ultra-wide-angle imaging, the field of view is expanded more than three times, accurately capturing peripheral retinal lesions. It employs red, blue, green, and infrared four-laser confocal scanning for simultaneous imaging, displaying images in five distinct layers. The multi-modal integrated design enables efficient and precise screening and diagnosis of fundus diseases. It holds significant clinical value in the accurate diagnosis and staging of macular diseases, vascular diseases, congenital diseases, hereditary diseases, systemic diseases, ocular trauma, and peripheral retinal degeneration. Experts believe that domestically produced imaging equipment represented by brands like Yesight has surpassed some imported products in terms of image clarity, scanning depth, and real-time imaging speed, achieving a technological breakthrough.
Yesight is an innovative ophthalmic optical equipment platform technology enterprise that focuses on the research and development and transformation of innovative ophthalmic medical devices. It integrates R&D, production, sales, and AI big data research. Headquartered in the Jiangsu Medical Device Technology Park (Medpark), the company also has a research institute in Japan.At this stage, the team is focusing on SLO (Scanning Laser Ophthalmoscope) for ophthalmic diagnosis. Relying on R&D resources from both China and Japan, as well as an international team, Yesight is continuously promoting innovation in ophthalmic diagnostic technology and equipment iteration.
Yesight's outstanding performance at the conference fully demonstrated Medpark's significant achievements in nurturing high-tech innovative enterprises and promoting technological innovation and industrial transformation of domestically produced high-end medical devices. Medpark will continue to focus on breakthrough innovative technologies, fostering new momentum for the high-quality development of the regional medical device and broader health industry.
